HCPLive

Caffeine in Maternity Linked to Low Birth Weight Babies

THURSDAY, Feb. 28 (HealthDay News) -- Maternal caffeine intake is associated with lower birth weight and increased odds of a baby being small for gestational age (SGA), but does not increase the risk of spontaneous preterm delivery (PTD), according to research published online Feb. 19 in BMC Medicine.

Verena Sengpiel, MD, of the Sahlgrenska University Hospital, in Gothenburg, Sweden, and colleagues studied the association between maternal caffeine intake from different sources on gestational length, the risk for spontaneous PTD, birth weight, and SGA in a cohort of 59,123 Norwegian women with uncomplicated pregnancies giving birth to a live singleton.

The researchers found that caffeine from coffee, but not other sources, was linked to a significantly longer gestation of 8 hours/100 mg/day. There was no correlation between total caffeine or caffeine from coffee with the risk of spontaneous PTD. Caffeine intake from different sources correlated with lower birth weight (approximately 20-30 g/100 mg/day). Compared to intake of 0 to 50 mg/day, caffeine intake of 200 to 30 mg/day correlated with significantly increased odds for SGA.

"Coffee, but not caffeine, consumption was associated with marginally increased gestational length but not with spontaneous PTD risk. Caffeine intake was consistently associated with decreased birth weight and increased odds of SGA," the authors write. "This might have clinical implications as even caffeine consumption below the recommended maximum (200 mg/day in the Nordic countries and USA, 300 mg/day according to the World Health Organization) was associated with increased risk for SGA."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

After studying the reasons for evacuation from theater, between 2004 to 2007, Steven P. Cohen, MD, Johns Hopkins School of Medicine, found that the number one reason each year revolved around muscular skeletal injuries.
As the use of long-term opioid therapy to treat chronic pain continues to be a hotly debated topic, a new study in PAIN analyzed the extent to which patients misuse their medications and the risk of addiction associated with these behaviors.
By using genetically modified corn, researchers are another step closer to an oral vaccine for hepatitis B, a virus that has infected almost two billion people worldwide.
The pain that typically accompanies osteoarthritis may be associated with excess mortality among middle-aged women, British scientists reported.
$vAR$